SHAKIRAT AKHIGBE: Open Payments
NPI 1417208125 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$149 in 4 payments from 4 companies in 2025. Trend: 2023 $595 · 2024 $629 · 2025 $149
Food & beverage: $149
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 1 | $82 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
Products named: XIFAXAN, JARDIANCE.
Industry payments across GA — which companies pay providers there.
